Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Neurodegenerative Diseases
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Molecular Targets
100%
Neurodegeneration
33%
Clinical Trials
16%
Disease Stage
16%
Alzheimer
16%
Beneficial Effects
16%
Amyotrophic Lateral Sclerosis
16%
Epidemiological Study
16%
Neuron Cells
16%
Multiple Sclerosis
16%
Parkinson
16%
Microglial Cells
16%
Drug Use
16%
Endothelial Cells
16%
Cell Targeting
16%
Secretase
16%
NF-B
16%
Conflicting Results
16%
Preventive Treatment
16%
Decreased Risk
16%
Astrocyte Cells
16%
Cyclooxygenase-1 (COX-1)
16%
Therapeutic Function
16%
Pharmacology, Toxicology and Pharmaceutical Science
Molecular Target
100%
Degenerative Disease
100%
Non-Steroidal Anti-Inflammatory Drug
100%
Nerve Degeneration
33%
Diseases
33%
Clinical Trial
16%
Amyotrophic Lateral Sclerosis
16%
Multiple Sclerosis
16%
Peroxisome Proliferator Activated Receptor
16%
Prostaglandin Synthase
16%
Secretase
16%
Medicine and Dentistry
Degenerative Disease
100%
Nonsteroid Antiinflammatory Agent
100%
Neurodegeneration
33%
Diseases
33%
Multiple Sclerosis
16%
Endothelial Cell
16%
Drug Use
16%
Amyotrophic Lateral Sclerosis
16%
Peroxisome Proliferator Activated Receptor
16%
Secretase
16%
Prostaglandin Synthase
16%
Clinical Trial
16%
Microglia
16%
Astrocyte
16%
Neuroscience
Non-Steroidal Anti-Inflammatory Drug
100%
Neurodegenerative Disorder
100%
Neurodegeneration
33%
Multiple Sclerosis
16%
Peroxisome Proliferator-Activated Receptor
16%
Cyclooxygenase
16%
Microglia
16%
Astrocyte
16%
Amyotrophic Lateral Sclerosis
16%
Secretase
16%